Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 1
2007 1
2010 4
2011 2
2012 2
2013 7
2014 6
2015 5
2016 8
2017 7
2018 7
2019 6
2020 6
2021 12
2022 11
2023 7
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of Dose Escalation of Oral 5-Aminosalicylic Acid for Ulcerative Colitis With a Mayo Endoscopic Subscore of 1: An Open Label Randomized Controlled Trial.
Fukuda T, Aoki Y, Kiyohara H, Yokoyama A, Nakazawa A, Yoshimatsu Y, Sugimoto S, Nanki K, Mikami Y, Fukuhara K, Mizuno S, Sujino T, Mutaguchi M, Takabayashi K, Morohoshi Y, Hosoda Y, Ogata H, Iwao Y, Naganuma M, Kanai T. Fukuda T, et al. Among authors: kiyohara h. Inflamm Bowel Dis. 2024 Apr 24:izae088. doi: 10.1093/ibd/izae088. Online ahead of print. Inflamm Bowel Dis. 2024. PMID: 38655866
Recent steroid use and the relapse risk in ulcerative colitis patients with endoscopic healing.
Fukuda T, Yamazaki H, Miyatani Y, Sawada T, Shibuya N, Fukuo Y, Kiyohara H, Morikubo H, Tominaga K, Kakimoto K, Imai T, Yaguchi K, Yamamoto S, Ando K, Nishimata N, Yoshihara T, Andoh A, Hibi T, Matsuoka K; IBD Terakoya Group. Fukuda T, et al. Among authors: kiyohara h. Aliment Pharmacol Ther. 2024 Apr 23. doi: 10.1111/apt.18013. Online ahead of print. Aliment Pharmacol Ther. 2024. PMID: 38651779
Real-world NUDT15 genotyping and thiopurine treatment optimization in inflammatory bowel disease: a multicenter study.
Makuuchi M, Kakuta Y, Umeno J, Fujii T, Takagawa T, Ibuka T, Miura M, Sasaki Y, Takahashi S, Nakase H, Kiyohara H, Tominaga K, Shimodaira Y, Hiraoka S, Ueno N, Yanai S, Yoshihara T, Kakimoto K, Matsuoka K, Hayashi R, Nanjo S, Iwama I, Ishiguro Y, Chiba H, Endo K, Kagaya T, Fukuda T, Sakata Y, Kudo T, Takagi T, Takahashi K, Naganuma M, Shinozaki M, Ogata N, Tanaka H, Narimatsu K, Miyazaki H, Ishige T, Onodera M, Hashimoto Y, Nagai H, Shimoyama Y, Naito T, Moroi R, Shiga H; Post-MENDEL study group; Kinouchi Y, Andoh A, Hisamatsu T, Masamune A. Makuuchi M, et al. Among authors: kiyohara h. J Gastroenterol. 2024 Apr 8. doi: 10.1007/s00535-024-02099-7. Online ahead of print. J Gastroenterol. 2024. PMID: 38589597
Video capsule endoscopy in overt and occult obscure gastrointestinal bleeding: Insights from a single-center, observational study in Japan.
Tojo A, Sujino T, Hayashi Y, Kamiya KJLL, Sato M, Hinako S, Yoshimatsu Y, Kinoshita S, Kiyohara H, Mikami Y, Takabayashi K, Kato M, Ogata H, Kanai T, Hosoe N. Tojo A, et al. Among authors: kiyohara h. DEN Open. 2024 Apr 1;4(1):e354. doi: 10.1002/deo2.354. eCollection 2024 Apr. DEN Open. 2024. PMID: 38567032 Free PMC article.
Clinical outcomes of patients with remitting ulcerative colitis after discontinuation of indigo naturalis.
Shimada F, Yoshimatsu Y, Sujino T, Fukuda T, Aoki Y, Hayashi Y, Tojo A, Kawaguchi T, Kiyohara H, Sugimoto S, Nanki K, Mikami Y, Miyamoto K, Takabayashi K, Hosoe N, Kato M, Ogata H, Naganuma M, Kanai T. Shimada F, et al. Among authors: kiyohara h. Sci Rep. 2024 Mar 9;14(1):5778. doi: 10.1038/s41598-024-56543-y. Sci Rep. 2024. PMID: 38459203 Free PMC article.
White Blood Cell Counts and Future Relapse in Ulcerative Colitis under Low-Dose Thiopurine Treatment in Real-World Practice: A 3-Year Japanese Multi-Center Retrospective Cohort Study.
Kiyohara H, Yamazaki H, Moriya K, Akimoto N, Kawai S, Takenaka K, Fukuda T, Tominaga K, Umeno J, Shinzaki S, Honzawa Y, Takagi T, Ichikawa H, Endo T, Ozaki R, Andoh A, Matsuoka K, Hibi T, Kobayashi T; IBD Terakoya Group. Kiyohara H, et al. Inflamm Intest Dis. 2023 Dec 28;9(1):1-10. doi: 10.1159/000535889. eCollection 2024 Jan-Dec. Inflamm Intest Dis. 2023. PMID: 38298887 Free PMC article.
Gastrointestinal symptoms in COVID-19 and disease severity: a Japanese registry-based retrospective cohort study.
Matsubara Y, Kiyohara H, Mikami Y, Nanki K, Namkoong H, Chubachi S, Tanaka H, Azekawa S, Sugimoto S, Yoshimatsu Y, Sujino T, Takabayashi K, Hosoe N, Sato T, Ishii M, Hasegawa N, Okada Y, Koike R, Kitagawa Y, Kimura A, Imoto S, Miyano S, Ogawa S, Fukunaga K, Kanai T; Japan COVID-19 Task Force. Matsubara Y, et al. Among authors: kiyohara h. J Gastroenterol. 2024 Mar;59(3):195-208. doi: 10.1007/s00535-023-02071-x. Epub 2024 Jan 25. J Gastroenterol. 2024. PMID: 38270615
Immunomodulators after the discontinuation of anti-tumor necrosis factor-alpha antibody treatment and relapse in ulcerative colitis: A multicenter cohort study.
Asonuma K, Ozeki K, Yamazaki H, Okabayashi S, Okano S, Ozaki R, Nishimata N, Kiyohara H, Ichinari N, Kobayashi T, Yamada M, Matsubayashi M, Yokoyama Y, Arimitsu S, Umeno J, Munetomo Y, Andoh A, Shinzaki S; IBD Terakoya Group. Asonuma K, et al. Among authors: kiyohara h. J Gastroenterol Hepatol. 2024 Jan;39(1):66-73. doi: 10.1111/jgh.16376. Epub 2023 Oct 12. J Gastroenterol Hepatol. 2024. PMID: 37823425
86 results